Finance

Lists
BXP:LON
Beximco Pharmaceuticals GDR
GBX 53,99
-0,02%
(-0,0100) 1D
2 Okt., 16:30:00 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for BXP...
Open
GBX 51,70
High
GBX 53,99
Low
GBX 51,35
Avg. vol.
24,96 k
Volume
36,86 k
52-wk high
GBX 65,00
52-wk low
GBX 36,70
Shares outstanding
405,56 m
No. of employees
1 k
Open
GBX 51,70
High
GBX 53,99
Low
GBX 51,35
Avg. vol.
24,96 k
Volume
36,86 k
52-wk high
GBX 65,00
52-wk low
GBX 36,70
Shares outstanding
405,56 m
No. of employees
1 k
News stories
From web sources and news partners
About Beximco Pharmaceuticals GDR
CEO-
Employees1,22 k
Founded1976
HeadquartersDhaka, Dhaka District, Bangladesj
SectorPharmaceutical industry
Previous reportsAll values in BDT
Loading Previous Earnings...
Revenue
Net income
All values in BDT
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
12,50 mjd
13,79 mjd
14,01 mjd
13,63 mjd
Cost of goods sold
7,17 mjd
7,16 mjd
7,05 mjd
6,93 mjd
Cost of revenue
7,17 mjd
7,16 mjd
7,05 mjd
6,93 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 mjd
3,50 mjd
3,84 mjd
3,84 mjd
Operating expense
3,10 mjd
3,50 mjd
3,84 mjd
3,84 mjd
Total operating expenses
10,27 mjd
10,66 mjd
10,90 mjd
10,77 mjd
Operating income
2,23 mjd
3,14 mjd
3,11 mjd
2,86 mjd
Other non operating income
113,91 m
129,13 m
203,65 m
193,27 m
EBT including unusual items
2,17 mjd
3,12 mjd
3,12 mjd
2,91 mjd
EBT excluding unusual items
2,13 mjd
3,12 mjd
3,12 mjd
2,91 mjd
Income tax expense
427,45 m
718,41 m
732,06 m
652,35 m
Effective tax rate
19,74%
23,03%
23,43%
22,44%
Other operating expenses
-
-
-
-
Net income
1,71 mjd
2,36 mjd
2,36 mjd
2,22 mjd
Net profit margin
13,67%
17,13%
16,83%
16,29%
Earnings per share
-
-
-
-
Interest and investment income
27,30 m
39,60 m
-
-
Interest expense
-161,48 m
-186,31 m
-187,24 m
-146,06 m
Net interest expenses
-134,17 m
-146,71 m
-187,24 m
-146,06 m
Depreciation and amortization charges
-
-
-
-
EBITDA
2,42 mjd
3,62 mjd
3,68 mjd
3,39 mjd
Gain or loss from assets sale
-29,40 m
111,00 k
-9,16 m
-4,92 m
AI content may include mistakes. Learn more
Google-programme